title: Drug transport to brain with targeted liposomes.
abstract: Antibody-conjugated liposomes or immunoliposomes are particulate drug carriers that can be used to direct encapsulated drug molecules to diseased tissues or organs. The present review discusses examples of successful applications of this technology to achieve drug transport across the blood-brain barrier. In addition, information will be provided on practical aspects such as phospholipid compositions of liposomes, antibody coupling technologies, large-scale production of liposomes, and obstacles related to drug loading of the carrier. Prospects of future uses of immunoliposome-based drug delivery systems such as gene therapy of the brain and clinical trials are discussed.
authors.affiliation: Department of Research and Division of Clinical Pharmacology, University Hospital Basel, CH-4031 Basel, Switzerland.
authors.forename: Anita
authors.initials: A
authors.lastname: Schnyder
authors.forename: Jörg
authors.initials: J
authors.lastname: Huwyler
mesh_terms: D000818:Animals; D001921:Brain / Q000378:metabolism*; D016503:Drug Delivery Systems; D006801:Humans; D007120:Immunochemistry; D008081:Liposomes / Q000737:chemistry; D010599:Pharmacokinetics
chemical_list: D008081:Liposomes
references.citation: J Cereb Blood Flow Metab. 2002 Feb;22(2):223-31
references.pmid: 11823720
references.citation: Biochim Biophys Acta. 1992 Apr 13;1105(2):193-200
references.pmid: 1586658
references.citation: Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):247-79
references.pmid: 11259843
references.citation: J Liposome Res. 2002 Feb-May;12(1-2):5-12
references.pmid: 12604033
references.citation: Science. 1997 Feb 7;275(5301):820-2
references.pmid: 9012346
references.citation: Biochim Biophys Acta. 1995 Nov 1;1239(2):157-67
references.pmid: 7488620
references.citation: Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):4771-5
references.pmid: 2052557
references.citation: Gene Ther. 1998 Jun;5(6):809-19
references.pmid: 9747461
references.citation: Adv Drug Deliv Rev. 1995 Jul;15(1-3):109-146
references.pmid: 35524386
references.citation: Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12754-9
references.pmid: 11592987
references.citation: Biophys J. 2000 Sep;79(3):1438-46
references.pmid: 10969005
references.citation: Clin Pharmacokinet. 2003;42(5):419-36
references.pmid: 12739982
references.citation: Int J Pharm. 2001 Feb 19;214(1-2):63-5
references.pmid: 11282238
references.citation: Clin Cancer Res. 2000 May;6(5):1949-57
references.pmid: 10815920
references.citation: Biochim Biophys Acta. 1995 Jul 26;1237(2):99-108
references.pmid: 7632714
references.citation: J Nucl Med. 1975 Jun;16(6):483-7
references.pmid: 1159503
references.citation: Int J Pharm. 1999 Apr 20;181(1):79-93
references.pmid: 10370205
references.citation: Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7567-72
references.pmid: 10840060
references.citation: Biochim Biophys Acta. 1995 Aug 17;1245(1):9-16
references.pmid: 7654771
references.citation: Pharm Res. 2001 Aug;18(8):1091-5
references.pmid: 11587478
references.citation: Cancer Invest. 2001;19(4):424-36
references.pmid: 11405181
references.citation: Nat Biotechnol. 1997 Feb;15(2):167-73
references.pmid: 9035144
references.citation: J Magn Reson Imaging. 1994 May-Jun;4(3):497-505
references.pmid: 7802866
references.citation: J Neuroimmunol. 2000 Feb 1;103(1):8-15
references.pmid: 10674984
references.citation: Brain Res. 1995 Jun 19;683(2):164-71
references.pmid: 7552351
references.citation: J Control Release. 1998 Apr 30;53(1-3):39-48
references.pmid: 9741912
references.citation: Biochim Biophys Acta. 1995 Nov 1;1239(2):145-56
references.pmid: 7488619
references.citation: FEBS Lett. 1987 Oct 19;223(1):42-6
references.pmid: 3666140
references.citation: J Pharm Sci. 1996 Jun;85(6):612-8
references.pmid: 8773958
references.citation: Trends Pharmacol Sci. 1994 Jul;15(7):215-20
references.pmid: 7940982
references.citation: J Pharmacol Exp Ther. 1991 Oct;259(1):66-70
references.pmid: 1920136
references.citation: J Biol Chem. 1982 Jan 10;257(1):286-8
references.pmid: 7053372
references.citation: Adv Drug Deliv Rev. 1999 Nov 10;40(1-2):3-18
references.pmid: 10837777
references.citation: J Microencapsul. 1998 Mar-Apr;15(2):137-51
references.pmid: 9532520
references.citation: Neurology. 2002 Apr 23;58(8 Suppl 4):S23-31
references.pmid: 11971123
references.citation: Proc Natl Acad Sci U S A. 1988 Sep;85(18):6949-53
references.pmid: 3413128
references.citation: Biochim Biophys Acta. 1991 Feb 25;1062(2):142-8
references.pmid: 2004104
references.citation: Int J Pharm. 1999 Mar 1;179(1):85-95
references.pmid: 10053205
references.citation: J Lab Clin Med. 1993 Nov;122(5):487-8
references.pmid: 8228564
references.citation: Mol Ther. 2002 Jul;6(1):67-72
references.pmid: 12095305
references.citation: Hum Gene Ther. 2003 Jan 1;14(1):1-12
references.pmid: 12573054
references.citation: Ann N Y Acad Sci. 1983;421:424-33
references.pmid: 6202216
references.citation: FEBS Lett. 1991 Jun 24;284(2):263-6
references.pmid: 2060647
references.citation: FEBS Lett. 1993 Dec 28;336(3):485-90
references.pmid: 8282116
references.citation: J Gene Med. 2002 Mar-Apr;4(2):183-94
references.pmid: 11933219
references.citation: Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11460-4
references.pmid: 1763060
references.citation: J Drug Target. 2000;8(6):435-46
references.pmid: 11328669
references.citation: J Biol Chem. 1994 Feb 4;269(5):3198-204
references.pmid: 8106354
references.citation: Anticancer Res. 2003 Jan-Feb;23(1A):439-42
references.pmid: 12680245
references.citation: Clin Cancer Res. 2004 Jun 1;10(11):3667-77
references.pmid: 15173073
references.citation: J Pharmacol Exp Ther. 1997 Sep;282(3):1541-6
references.pmid: 9316870
references.citation: Biochim Biophys Acta. 2001 Aug 6;1513(2):207-16
references.pmid: 11470092
references.citation: Biochim Biophys Acta. 1995 Nov 1;1239(2):133-44
references.pmid: 7488618
references.citation: J Neurochem. 1990 Jun;54(6):1882-8
references.pmid: 2338547
references.citation: Biochim Biophys Acta. 1995 Mar 8;1234(1):74-80
references.pmid: 7880861
references.citation: Biochim Biophys Acta. 1992 Jun 29;1135(3):269-74
references.pmid: 1623013
references.citation: Bioconjug Chem. 2000 May-Jun;11(3):380-6
references.pmid: 10821654
references.citation: Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2076-80
references.pmid: 8134351
references.citation: Cancer Res. 2004 Apr 1;64(7):2572-9
references.pmid: 15059914
references.citation: Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):14164-9
references.pmid: 8943078
references.citation: J Biol Chem. 1997 Jan 24;272(4):2382-8
references.pmid: 8999949
references.citation: J Neurooncol. 2003 Mar-Apr;62(1-2):47-59
references.pmid: 12749702
references.citation: J Gene Med. 2003 Apr;5(4):311-23
references.pmid: 12692865
references.citation: Br J Cancer. 2003 Oct 20;89(8):1545-51
references.pmid: 14562030
references.citation: Nature. 1996 Apr 11;380(6574):561-2
references.pmid: 8606781
references.citation: Science. 1997 Feb 7;275(5301):810-4
references.pmid: 9012343
references.citation: Pharm Res. 1996 Apr;13(4):604-10
references.pmid: 8710754
references.citation: FEBS Lett. 1996 May 20;386(2-3):243-6
references.pmid: 8647291
references.citation: J Clin Invest. 1997 Oct 1;100(7):1804-12
references.pmid: 9312181
references.citation: Cancer Res. 1994 Feb 15;54(4):987-92
references.pmid: 8313389
references.citation: Biochem J. 2004 Jan 1;377(Pt 1):61-7
references.pmid: 14516278
references.citation: Biochem Biophys Res Commun. 1978 Dec 14;85(3):983-90
references.pmid: 736970
references.citation: Ann Oncol. 2004 Mar;15(3):517-25
references.pmid: 14998859
references.citation: Mol Ther. 2003 Jan;7(1):11-8
references.pmid: 12573613
references.citation: J Neurooncol. 2004 May;68(1):1-9
references.pmid: 15174514